0001209191-11-031283.txt : 20110526 0001209191-11-031283.hdr.sgml : 20110526 20110526163958 ACCESSION NUMBER: 0001209191-11-031283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110524 FILED AS OF DATE: 20110526 DATE AS OF CHANGE: 20110526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Banham John Michael Middlecott CENTRAL INDEX KEY: 0001357635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 11874565 MAIL ADDRESS: STREET 1: C/O CYCLACEL PHARMACEUTICALS, INC. STREET 2: 200 CONNELL DRIVE, SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 c17944_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2011-05-24 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001357635 Banham John Michael Middlecott 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 1 0 0 0 Option 1.53 2011-05-24 4 A 0 25000 0 A 2021-05-24 Common Stock 25000 25000 D These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis. The options were granted to Sir Banham for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. /s/ John Michael Middlecott Banham 2011-05-26